Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis

Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis

Objective: The prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NAFLD/NASH) is increasing. NAFLD/NASH may progress to cirrhosis and hepatocellular carcinoma. However, most patients with NAFLD/NASH will die from a vascular cause. There are no approved pharmacological...

Full description

Bibliographic Details
Main Authors: Maryam Mahjoubin-Tehran, Antonio De Vincentis, Dimitri P. Mikhailidis, Stephen L. Atkin, Christos S. Mantzoros, Tannaz Jamialahmadi, Amirhossein Sahebkar
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Molecular Metabolism
Subjects:
Non-alcoholic fatty liver disease
Liver biopsy
Non-alcoholic steatohepatitis
Online Access:http://www.sciencedirect.com/science/article/pii/S221287782030123X

Internet

http://www.sciencedirect.com/science/article/pii/S221287782030123X

Similar Items